This case study shows how MedPharm solved solubility challenges in a small molecule formulation. The team identified the root cause of drug precipitation and optimized excipient selection. Through targeted solubility studies and formulation design, stability improved and regulatory risk was reduced. The result was a robust, scalable formulation that enabled continued development.